Liver Cancer, Adult Clinical Trial
Official title:
Analgesia by Transversus Abdominis Plane Nerve Block in Patients Undergoing Liver Resection
The indications liver cancer surgery currently booming due to the increase in surgical
techniques and instruments for a more secure resection of liver tissue with a significant
reduction in bleeding or surgical complications. This allowed to expand surgical indications
in the most fragile patients so assuming optimized anesthetic care.
So far, the technique of analgesia reference to this surgery remains administration of
morphine analgesia via a device controlled by the patient (PCA) for epidural analgesia is
against-indicated because of induced bleeding disorders by surgery.
Rafi then McDonnell in 2007 have described a new technique of loco regional anesthesia, the
abdomen of the Transversus Abdominis Plane (TAP) nerve block(TAP), which allows selective
anesthesia of the abdominal wall. But parietal pain related muscular and nervous sagging
surgical approach represent a significant share of post operative pain.
This study proposes an evaluation of the abdomen transverse blocks in hepatectomy.
n/a
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT02967848 -
Liver Function Investigation With SPECT
|
||
| Recruiting |
NCT03674073 -
A Study Combining Personalized Neoantigen-based Dendritic Cell Vaccine With Microwave Ablation for the Treatment of Hepatocellular Carcinoma
|
Phase 1 | |
| Terminated |
NCT02704130 -
TAE and MWA Combination Therapy in Early-stage Hepatocellular Carcinoma
|
N/A | |
| Recruiting |
NCT04864054 -
T-Cell Therapy (ECT204) in Adults With Advanced HCC
|
Phase 2 | |
| Not yet recruiting |
NCT05195294 -
Study of HBV-TCR T Cells (LioCyx-M) as Monotherapy or as Combination With Lenvatinib for HBV-related HCC
|
Phase 1/Phase 2 | |
| Completed |
NCT02191878 -
Safety, Pharmacokinetics and Preliminary Anti-Tumor Activity of Intravenous TKM-080301 in Subjects With Advanced Hepatocellular Carcinoma
|
Phase 1/Phase 2 | |
| Terminated |
NCT00669136 -
Immunization With AFP + GM CSF Plasmid Prime and AFP Adenoviral Vector Boost in Patients With Hepatocellular Carcinoma
|
Phase 1 | |
| Active, not recruiting |
NCT04567615 -
A Study of Relatlimab in Combination With Nivolumab in Participants With Advanced Liver Cancer Who Have Never Been Treated With Immuno-oncology Therapy After Prior Treatment With Tyrosine Kinase Inhibitors
|
Phase 2 | |
| Recruiting |
NCT05705219 -
Development of 3DMPUS as a Decision Support Tool for Patients With Liver Tumors Undergoing Therapy
|
N/A |